JPWO2023145486A1 - - Google Patents

Info

Publication number
JPWO2023145486A1
JPWO2023145486A1 JP2023576781A JP2023576781A JPWO2023145486A1 JP WO2023145486 A1 JPWO2023145486 A1 JP WO2023145486A1 JP 2023576781 A JP2023576781 A JP 2023576781A JP 2023576781 A JP2023576781 A JP 2023576781A JP WO2023145486 A1 JPWO2023145486 A1 JP WO2023145486A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576781A
Other languages
Japanese (ja)
Other versions
JPWO2023145486A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023145486A1 publication Critical patent/JPWO2023145486A1/ja
Publication of JPWO2023145486A5 publication Critical patent/JPWO2023145486A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023576781A 2022-01-28 2023-01-13 Pending JPWO2023145486A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022011565 2022-01-28
PCT/JP2023/000786 WO2023145486A1 (ja) 2022-01-28 2023-01-13 フェソテロジンフマル酸塩含有製剤の製造方法

Publications (2)

Publication Number Publication Date
JPWO2023145486A1 true JPWO2023145486A1 (https=) 2023-08-03
JPWO2023145486A5 JPWO2023145486A5 (https=) 2024-06-26

Family

ID=87471342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576781A Pending JPWO2023145486A1 (https=) 2022-01-28 2023-01-13

Country Status (3)

Country Link
JP (1) JPWO2023145486A1 (https=)
TW (1) TWI836872B (https=)
WO (1) WO2023145486A1 (https=)

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003212769A (ja) * 2001-11-13 2003-07-30 Kotobuki Seiyaku Kk Ｌ−グルタミンおよびアズレンスルホン酸ナトリウムを含有する速崩錠または口腔内崩壊錠並びにその製造方法
JP2004035517A (ja) * 2002-07-08 2004-02-05 Wyeth Lederle Japan Ltd カルバペネム系抗生剤含有経口製剤
JP2005526020A (ja) * 2002-02-01 2005-09-02 ファイザー・プロダクツ・インク アジスロマイシンの乾式造粒配合物
JP2007169278A (ja) * 2005-12-20 2007-07-05 Pfizer Prod Inc Ｌｕｔｓ処置用の医薬組合せ
JP2009539802A (ja) * 2006-06-09 2009-11-19 シュバルツ ファルマ アクチェンゲゼルシャフト フェソテロジンを含む安定した医薬組成物
WO2012136839A1 (en) * 2011-04-08 2012-10-11 Lek Pharmaceuticals D.D. Dry formulation and pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
US20130236544A1 (en) * 2012-03-08 2013-09-12 Dr. Reddy's Laboratories Ltd. Stable pharmaceutical compositions of fesoterodine
WO2014138603A1 (en) * 2013-03-07 2014-09-12 Amneal Pharmaceuticals, LLC Stabilization of moisture-sensitive drugs
JP2018519305A (ja) * 2015-06-30 2018-07-19 ジェネンテック， インコーポレイテッド 薬物を含有する即放性錠剤及び錠剤の形成プロセス
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
WO2019206391A1 (en) * 2018-04-26 2019-10-31 Rontis Hellas S.A. Extended release pharmaceutical composition containing fesoterodine and process for the preparation thereof
WO2020090969A1 (ja) * 2018-10-31 2020-05-07 富士フイルム株式会社 抗腫瘍剤を含む医薬組成物の包装体

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003212769A (ja) * 2001-11-13 2003-07-30 Kotobuki Seiyaku Kk Ｌ−グルタミンおよびアズレンスルホン酸ナトリウムを含有する速崩錠または口腔内崩壊錠並びにその製造方法
JP2005526020A (ja) * 2002-02-01 2005-09-02 ファイザー・プロダクツ・インク アジスロマイシンの乾式造粒配合物
JP2004035517A (ja) * 2002-07-08 2004-02-05 Wyeth Lederle Japan Ltd カルバペネム系抗生剤含有経口製剤
JP2007169278A (ja) * 2005-12-20 2007-07-05 Pfizer Prod Inc Ｌｕｔｓ処置用の医薬組合せ
JP2009539802A (ja) * 2006-06-09 2009-11-19 シュバルツ ファルマ アクチェンゲゼルシャフト フェソテロジンを含む安定した医薬組成物
WO2012136839A1 (en) * 2011-04-08 2012-10-11 Lek Pharmaceuticals D.D. Dry formulation and pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
US20130236544A1 (en) * 2012-03-08 2013-09-12 Dr. Reddy's Laboratories Ltd. Stable pharmaceutical compositions of fesoterodine
WO2014138603A1 (en) * 2013-03-07 2014-09-12 Amneal Pharmaceuticals, LLC Stabilization of moisture-sensitive drugs
JP2018519305A (ja) * 2015-06-30 2018-07-19 ジェネンテック， インコーポレイテッド 薬物を含有する即放性錠剤及び錠剤の形成プロセス
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
WO2019206391A1 (en) * 2018-04-26 2019-10-31 Rontis Hellas S.A. Extended release pharmaceutical composition containing fesoterodine and process for the preparation thereof
WO2020090969A1 (ja) * 2018-10-31 2020-05-07 富士フイルム株式会社 抗腫瘍剤を含む医薬組成物の包装体

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MAXIMILIANO S. SANGOI ET AL.: ""Fesoterodine stress degradation behavior by liquid chromatography coupled to ultraviolet detection", TALANTA, vol. 84, no. 4, JPN6025049475, 2011, pages 1068 - 1079, ISSN: 0005744206 *
MAXIMILIANO S. SANGOI ET AL.: ""Photochemistry of a novel antimuscarinic drug fesoterodine and identification of its photodegradat", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A: CHEMISTRY, vol. 256, JPN6025049476, 2013, pages 16 - 22, ISSN: 0005744207 *

Also Published As

Publication number Publication date
WO2023145486A1 (ja) 2023-08-03
TW202329927A (zh) 2023-08-01
TWI836872B (zh) 2024-03-21

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR102022017795A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13141U (https=)
BY13151U (https=)
BY13137U (https=)
BY13138U (https=)
BY13139U (https=)
BY13140U (https=)
BY13135U (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240403

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240403

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250603

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250801

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260428